| Bioactivity | PPARδ/γ agonist 1 is a potent dual PPAR delta/gamma inhibitor. PPARδ/γ agonist 1 can be used for Alzheimer’s disease research[1]. |
| In Vivo | PPARδ/γ agonist 1 (1 mg/kg; i.g.; daily, for 16 days; STZ-mediated Long Evans rats) restores STZ-mediated impairments of motor function[1]. Animal Model: |
| Name | PPARδ/γ agonist 1 |
| CAS | 1257641-15-8 |
| Formula | C25H27NO5 |
| Molar Mass | 421.49 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Tong M, et, al. T3D-959: A Multi-Faceted Disease Remedial Drug Candidate for the Treatment of Alzheimer's Disease. J Alzheimers Dis. 2016;51(1):123-38. |